408 related articles for article (PubMed ID: 3301480)
1. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
[TBL] [Abstract][Full Text] [Related]
2. The natural history of pre-type 1 (insulin-dependent) diabetes mellitus in patients with autoimmune endocrine diseases.
Betterle C; Presotto F; Magrin L; Pedini B; Moro L; Caretto A; Zanchetta R
Diabetologia; 1994 Jan; 37(1):95-103. PubMed ID: 8150236
[TBL] [Abstract][Full Text] [Related]
3. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function.
Seissler J; Hering B; Richter W; Glück M; Yassin N; Bretzel RG; Boehm BO; Federlin K; Scherbaum WA
Diabetologia; 1992 Jun; 35(6):550-4. PubMed ID: 1612228
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients.
Thivolet C; Beaufrère B; Geburher L; Chatelain P; Orgiazzi J; François R
Diabetologia; 1991 Mar; 34(3):186-91. PubMed ID: 1884891
[TBL] [Abstract][Full Text] [Related]
6. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.
Bärmeier H; McCulloch DK; Neifing JL; Warnock G; Rajotte RV; Palmer JP; Lernmark A
Diabetologia; 1991 Oct; 34(10):727-33. PubMed ID: 1959705
[TBL] [Abstract][Full Text] [Related]
7. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.
Deschamps I; Boitard C; Hors J; Busson M; Marcelli-Barge A; Mogenet A; Robert JJ
Diabetologia; 1992 Oct; 35(10):951-7. PubMed ID: 1451952
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children.
Landin-Olsson M; Palmer JP; Lernmark A; Blom L; Sundkvist G; Nyström L; Dahlquist G
Diabetologia; 1992 Nov; 35(11):1068-73. PubMed ID: 1473617
[TBL] [Abstract][Full Text] [Related]
9. Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.
Thivolet C; Beaufrére B; Bétuel H; Gebuhrer L; Chatelain P; Durand A; Tourniaire J; François R
Diabetologia; 1988 Oct; 31(10):741-6. PubMed ID: 3071483
[TBL] [Abstract][Full Text] [Related]
10. Islet-cell antibodies as predictors of the later development of type 1 (insulin-dependent) diabetes. A study in identical twins.
Johnston C; Millward BA; Hoskins P; Leslie RD; Bottazzo GF; Pyke DA
Diabetologia; 1989 Jun; 32(6):382-6. PubMed ID: 2668086
[TBL] [Abstract][Full Text] [Related]
11. Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes.
Dean BM; Becker F; McNally JM; Tarn AC; Schwartz G; Gale EA; Bottazzo GF
Diabetologia; 1986 May; 29(5):339-42. PubMed ID: 3522332
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of islet cell antibodies, insulin antibodies and hyperglycaemia in 2291 schoolchildren.
Bergua M; Solé J; Marion G; Perez MC; Recasens A; Fernàndez J; Casamitjana R; Gomis R
Diabetologia; 1987 Sep; 30(9):724-6. PubMed ID: 3322914
[TBL] [Abstract][Full Text] [Related]
13. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
Pietropaolo M; Becker DJ; LaPorte RE; Dorman JS; Riboni S; Rudert WA; Mazumdar S; Trucco M
Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
Ferber KM; Keller E; Albert ED; Ziegler AG
J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
[TBL] [Abstract][Full Text] [Related]
15. Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse.
Reddy S; Bibby NJ; Elliott RB
Diabetologia; 1988 May; 31(5):322-8. PubMed ID: 3294069
[TBL] [Abstract][Full Text] [Related]
16. Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.
Karjalainen J; Knip M; Hyöty H; Leinikki P; Ilonen J; Käär ML; Akerblom HK
Diabetologia; 1988 Mar; 31(3):146-52. PubMed ID: 3286341
[TBL] [Abstract][Full Text] [Related]
17. Evidence of delayed beta-cell destruction in type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies.
Mustonen A; Knip M; Huttunen NP; Puukka R; Käär ML; Akerblom HK
Diabetologia; 1984 Oct; 27(4):421-6. PubMed ID: 6391985
[TBL] [Abstract][Full Text] [Related]
18. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration].
Majkowska L
Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111
[TBL] [Abstract][Full Text] [Related]
19. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
[TBL] [Abstract][Full Text] [Related]
20. Complement-fixing islet-cell antibodies in type I diabetes and in susceptible patients with autoimmune diseases.
Betterle C; Caretto A; Tiengo A; Trevisan A
Lancet; 1980 Jun; 1(8183):1418-9. PubMed ID: 6104205
[No Abstract] [Full Text] [Related]
[Next] [New Search]
